Editas Medicine (EDIT) Other Non-Current Liabilities (2015 - 2025)

Editas Medicine (EDIT) has 9 years of Other Non-Current Liabilities data on file, last reported at $2.8 million in Q4 2025.

• On a quarterly basis, Other Non-Current Liabilities fell 8.37% year-over-year to $2.8 million in Q4 2025; TTM through Dec 2025 was $2.8 million, a 8.37% decrease from a year earlier, with the FY2025 full-year figure at $2.8 million, down 8.37% from the prior year.
• Other Non-Current Liabilities for Q4 2025 stood at $2.8 million, down from $4.7 million in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for EDIT reached as high as $6.4 million in Q1 2025 and fell as low as $1.8 million in Q4 2023.
• Historically, Other Non-Current Liabilities has averaged $3.8 million across 3 years, with a median of $3.5 million in 2024.
• On a YoY basis, Other Non-Current Liabilities climbed as much as 83.21% in 2025 and fell as far as 8.37% in 2025.
• Year by year, Other Non-Current Liabilities stood at $1.8 million in 2023, then soared by 70.67% to $3.1 million in 2024, then retreated by 8.37% to $2.8 million in 2025.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $2.8 million in Q4 2025, $4.7 million in Q3 2025, and $4.6 million in Q2 2025.